Free Trial
NASDAQ:MOR

MorphoSys (MOR) Stock Price, News & Analysis

MorphoSys logo
$18.96 0.00 (0.00%)
As of 08/11/2025

About MorphoSys Stock (NASDAQ:MOR)

Key Stats

Today's Range
$18.96
$18.96
50-Day Range
$18.96
$18.96
52-Week Range
$4.18
$19.50
Volume
N/A
Average Volume
1.02 million shs
Market Capitalization
$2.86 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter.

MOR Stock News Headlines

REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).
Novartis shutters MorphoSys sites, lays off staff
Novartis raises mid-term sales guidance
See More Headlines

MOR Stock Analysis - Frequently Asked Questions

MorphoSys' stock was trading at $18.96 on January 1st, 2025. Since then, MOR shares have increased by 0.0% and is now trading at $18.96.

MorphoSys (MOR) raised $200 million in an IPO on Thursday, April 19th 2018. The company issued 8,300,000 shares at a price of $24.12 per share. Goldman Sachs, J.P. Morgan and Leerink Partners acted as the underwriters for the IPO and Berenberg Capital Markets and JMP Securities were co-managers.

Shares of MOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MorphoSys investors own include NVIDIA (NVDA), Broadcom (AVGO), Novo Nordisk A/S (NVO), e.l.f. Beauty (ELF), EMCOR Group (EME), Disc Medicine (IRON) and Builders FirstSource (BLDR).

Company Calendar

Today
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MOR
CIK
1340243
Employees
730
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.48)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$205.35 million
Net Margins
-226.79%
Pretax Margin
-225.77%
Return on Equity
-694.31%
Return on Assets
-22.55%

Debt

Debt-to-Equity Ratio
4.98
Current Ratio
1.38
Quick Ratio
1.38

Sales & Book Value

Annual Sales
$238.28 million
Price / Sales
11.99
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.35 per share
Price / Book
54.17

Miscellaneous

Outstanding Shares
150,621,000
Free Float
150,546,000
Market Cap
$2.86 billion
Optionable
Not Optionable
Beta
1.20

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:MOR) was last updated on 8/13/2025 by MarketBeat.com Staff
From Our Partners